ThyroidPrint is a global brand that aims to eliminate the diagnostic uncertainty of indeterminate thyroid nodules. If you have been diagnosed with a Bethesda III or IV nodule, there is a 15 to 30% risk of cancer. However, with ThyroidPrint, you can avoid unnecessary surgery due to the high probability that your nodule is benign.

This simple yet effective test is validated in the United States and LATAM and is designed to change the way indeterminate thyroid nodules are diagnosed and treated worldwide. ThyroidPrint has already conducted a significant number of tests, resulting in a substantial number of surgeries avoided. With years of experience and research, ThyroidPrint has partnered with renowned medical centers in both America and Europe.

These partnerships provide global reach to improve your quality of life. Backed by the accreditation of the College of American Pathologists (CAP) and complying with Chilean regulations, ThyroidPrint's laboratory ensures the highest standards in clinical diagnostics. Don't just take our word for it, hear what our patients have to say.

With testimonials from satisfied patients, ThyroidPrint has gained trust and credibility. Choose ThyroidPrint and keep your thyroid health in check